AAAAAA

   
Results: 1-22 |
Results: 22
PHARMACOKINETICS OF THE COMT INHIBITOR ENTACAPONE IN LIVER-FAILURE AND THE EFFECT OF ENTACAPONE ON LIVER-FUNCTION
Authors: GORDIN A PARSTIKAINEN PP MAKIMARTI M REINIKAINEN K
Citation: A. Gordin et al., PHARMACOKINETICS OF THE COMT INHIBITOR ENTACAPONE IN LIVER-FAILURE AND THE EFFECT OF ENTACAPONE ON LIVER-FUNCTION, Neurology, 50(4), 1998, pp. 6039-6039
POPULATION PHARMACODYNAMIC MODELING OF LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE RECEIVING ENTACAPONE
Authors: TROCONIZ IF NAUKKARINEN TH RUOTTINEN HM RINNE UK GORDIN A KARLSSON MO
Citation: If. Troconiz et al., POPULATION PHARMACODYNAMIC MODELING OF LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE RECEIVING ENTACAPONE, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 106-116
ENTACAPONE ENHANCES LEVODOPA-INDUCED REVERSAL OF MOTOR DISABILITY IN MPTP-TREATED COMMON MARMOSETS
Authors: SMITH LA GORDIN A JENNER P MARSDEN CD
Citation: La. Smith et al., ENTACAPONE ENHANCES LEVODOPA-INDUCED REVERSAL OF MOTOR DISABILITY IN MPTP-TREATED COMMON MARMOSETS, Movement disorders, 12(6), 1997, pp. 935-945
ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS
Authors: KIEBURTZ K SHOULSON I FAHN S MCDERMOTT M KOLLER W LEWITT P NUTT J KURTH M BREWER M LEW M WELSH M WATERS C BENNETT J ROSTRUFFNER E FEIGIN A GARDINER I KURLAN R HAMMERSTAD J STONE C JANKOVIC J BEACH J TETRUD J KELKER K STANDAERT DG GROWDON JH TENNIS M GRAEFE K MARK MH KELLY SJ PAHWA R MCGUIRE D HUBBLE J FACTOR SA BROWN DL TUITE P SIME E LANG DL GREENE P WINFIELD H PAULSON G ZOOG K WEEKS C SHULTS C FONTAINE D JUNCOS JL WOOD C SHANNON K JAGLIN JA TORNABENE J LANNON MC DAVIES R FRIEDMAN J TARIOT PN HALL WJ HERNDON R PFEIFFER RF PLUMB S CASACELI C RANDOLPH H BEHMAN H CONNORTON J DAY D RUDOLPH A PELUSIO R GUTHRIE B CLAUDE K ORME C BAKER D NOBEL R IRVINE C WATTS A GORDIN A HEIKKINEN H RITA H
Citation: K. Kieburtz et al., ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS, Annals of neurology, 42(5), 1997, pp. 747-755
COMT INHIBITION BY ENTACAPONE DOES NOT AFFECT GROWTH-HORMONE OR PROLACTIN SECRETION IN HEALTHY-VOLUNTEERS
Authors: KERANEN T GORDIN A KOULU M SCHEININ M ANTILA S SUNDBERG S WIKBERG T
Citation: T. Keranen et al., COMT INHIBITION BY ENTACAPONE DOES NOT AFFECT GROWTH-HORMONE OR PROLACTIN SECRETION IN HEALTHY-VOLUNTEERS, Journal of neural transmission, 103(6), 1996, pp. 729-736
SIMULTANEOUS INHIBITION OF CATECHOLAMINE-O-METHYLATION BY ENTACAPONE AND NEURONAL UPTAKE BY IMIPRAMINE - LACK OF INTERACTIONS
Authors: ILLI A SUNDBERG S OJALAKARLSSON P SCHEININ M GORDIN A
Citation: A. Illi et al., SIMULTANEOUS INHIBITION OF CATECHOLAMINE-O-METHYLATION BY ENTACAPONE AND NEURONAL UPTAKE BY IMIPRAMINE - LACK OF INTERACTIONS, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 273-276
QUANTITATIVE ASSESSMENT OF LEVODOPA RESPONSE TO PERIPHERAL COMT INHIBITION IN PARKINSONIAN-PATIENTS WITH END-OF-DOSE FLUCTUATIONS
Authors: RELJA MA RUOTTINEN HM VAKEVA M KYYRA T GORDIN A
Citation: Ma. Relja et al., QUANTITATIVE ASSESSMENT OF LEVODOPA RESPONSE TO PERIPHERAL COMT INHIBITION IN PARKINSONIAN-PATIENTS WITH END-OF-DOSE FLUCTUATIONS, Neurology, 46(2), 1996, pp. 67004-67004
SIMULTANEOUS INHIBITION OF CATECHOL-O-METHYLTRANSFERASE AND MONOAMINE-OXIDASE-A - EFFECTS ON HEMODYNAMICS AND CATECHOLAMINE METABOLISM IN HEALTHY-VOLUNTEERS
Authors: ILLI A SUNDBERG S OJALAKARLSSON P SCHEININ M GORDIN A
Citation: A. Illi et al., SIMULTANEOUS INHIBITION OF CATECHOL-O-METHYLTRANSFERASE AND MONOAMINE-OXIDASE-A - EFFECTS ON HEMODYNAMICS AND CATECHOLAMINE METABOLISM IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 450-457
EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS
Authors: AHTILA S KAAKKOLA S GORDIN A KORPELA K HEINAVAARA S KARLSSON M WIKBERG T TUOMAINEN P MANNISTO PT
Citation: S. Ahtila et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS, Clinical neuropharmacology, 18(1), 1995, pp. 46-57
ENTACAPONE INCREASES LEVODOPA RESPONSE IN A ONE-MONTH DOUBLE-BLIND-STUDY IN PARKINSONIAN-PATIENTS WITH FLUCTUATIONS
Authors: RUOTTINEN HM RINNE UK AHTILA S KARLSSON M KYYRO T GORDIN A
Citation: Hm. Ruottinen et al., ENTACAPONE INCREASES LEVODOPA RESPONSE IN A ONE-MONTH DOUBLE-BLIND-STUDY IN PARKINSONIAN-PATIENTS WITH FLUCTUATIONS, Neurology, 45(4), 1995, pp. 275-275
THE EFFECT OF ENTACAPONE ON THE DISPOSITION AND HEMODYNAMIC-EFFECTS OF INTRAVENOUS ISOPROTERENOL AND EPINEPHRINE
Authors: ILLI A SUNDBERG S OJALAKARLSSON P KORHONEN P SCHEININ M GORDIN A
Citation: A. Illi et al., THE EFFECT OF ENTACAPONE ON THE DISPOSITION AND HEMODYNAMIC-EFFECTS OF INTRAVENOUS ISOPROTERENOL AND EPINEPHRINE, Clinical pharmacology and therapeutics, 58(2), 1995, pp. 221-227
COMT INHIBITION BY HIGH-DOSE ENTACAPONE DOES NOT AFFECT HEMODYNAMICS BUT CHANGES CATECHOLAMINE METABOLISM IN HEALTHY-VOLUNTEERS AT REST ANDDURING EXERCISE
Authors: ILLI A SUNDBERG S KOULU M SCHEININ M HEINAVAARA S GORDIN A
Citation: A. Illi et al., COMT INHIBITION BY HIGH-DOSE ENTACAPONE DOES NOT AFFECT HEMODYNAMICS BUT CHANGES CATECHOLAMINE METABOLISM IN HEALTHY-VOLUNTEERS AT REST ANDDURING EXERCISE, International journal of clinical pharmacology and therapeutics, 32(11), 1994, pp. 582-588
GENERAL-PROPERTIES AND CLINICAL POSSIBILITIES OF NEW SELECTIVE INHIBITORS OF CATECHOL O-METHYLTRANSFERASE
Authors: KAAKKOLA S GORDIN A MANNISTO PT
Citation: S. Kaakkola et al., GENERAL-PROPERTIES AND CLINICAL POSSIBILITIES OF NEW SELECTIVE INHIBITORS OF CATECHOL O-METHYLTRANSFERASE, General pharmacology, 25(5), 1994, pp. 813-824
INHIBITION OF SOLUBLE CATECHOL-O-METHYLTRANSFERASE AND SINGLE-DOSE PHARMACOKINETICS AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF ENTACAPONE
Authors: KERANEN T GORDIN A KARLSSON M KORPELA K PENTIKAINEN PJ RITA H SCHULTZ E SEPPALA L WIKBERG T
Citation: T. Keranen et al., INHIBITION OF SOLUBLE CATECHOL-O-METHYLTRANSFERASE AND SINGLE-DOSE PHARMACOKINETICS AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF ENTACAPONE, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 151-157
EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS
Authors: NUTT JG WOODWARD WR BECKNER RM STONE CK BERGGREN K CARTER JH GANCHER ST HAMMERSTAD JP GORDIN A
Citation: Jg. Nutt et al., EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS, Neurology, 44(5), 1994, pp. 913-919
A DOSE-FINDING CLINICAL AND PHARMACOKINETIC STUDY OF ENTACAPONE AS ANADJUVANT TO LEVODOPA TREATMENT IN PARKINSONS-DISEASE
Authors: RUOTTINEN H RINNE UK AHTILA S GORDIN A
Citation: H. Ruottinen et al., A DOSE-FINDING CLINICAL AND PHARMACOKINETIC STUDY OF ENTACAPONE AS ANADJUVANT TO LEVODOPA TREATMENT IN PARKINSONS-DISEASE, Neurology, 44(4), 1994, pp. 10000258-10000259
COMT INHIBITION WITH ENTACAPONE IN PARKINSON PATIENTS TREATED EITHER WITH SINEMET OR SINEMET CR
Authors: TERAVAINEN H KAAKKOLA S GORDIN A AHTILA S RITA H
Citation: H. Teravainen et al., COMT INHIBITION WITH ENTACAPONE IN PARKINSON PATIENTS TREATED EITHER WITH SINEMET OR SINEMET CR, Neurology, 44(4), 1994, pp. 10000259-10000259
EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS
Authors: KAAKKOLA S TERAVAINEN H AHTILA S RITA H GORDIN A
Citation: S. Kaakkola et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS, Neurology, 44(1), 1994, pp. 77-80
EFFECT OF ENTACAPONE, A PERIPHERALLY ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ON THE MOTOR RESPONSE TO ACUTE TREATMENT WITH LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE
Authors: MERELLO M LEES AJ WEBSTER R BOVINGDON M GORDIN A
Citation: M. Merello et al., EFFECT OF ENTACAPONE, A PERIPHERALLY ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ON THE MOTOR RESPONSE TO ACUTE TREATMENT WITH LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 57(2), 1994, pp. 186-189
THE EFFECTS OF THE COMT INHIBITOR ENTACAPONE ON HEMODYNAMICS AND PERIPHERAL CATECHOLAMINE METABOLISM DURING EXERCISE
Authors: SUNDBERG S SCHEININ M ILLI A AKKILA J GORDIN A KERANEN T
Citation: S. Sundberg et al., THE EFFECTS OF THE COMT INHIBITOR ENTACAPONE ON HEMODYNAMICS AND PERIPHERAL CATECHOLAMINE METABOLISM DURING EXERCISE, British journal of clinical pharmacology, 36(5), 1993, pp. 451-456
EFFECTS OF ENTACAPONE, A COMT INHIBITOR, ON L-DOPA METABOLISM IN PARKINSONS-DISEASE (PD)
Authors: KAAKKOLA S TERAVAINEN H AHTILA S GORDIN A
Citation: S. Kaakkola et al., EFFECTS OF ENTACAPONE, A COMT INHIBITOR, ON L-DOPA METABOLISM IN PARKINSONS-DISEASE (PD), Neurology, 43(4), 1993, pp. 197-197
EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA
Authors: NUTT JG WOODWARD WR STONE CK BECKNER RM CARTER JH GANCHER ST HAMMERSTAD JP GORDIN A
Citation: Jg. Nutt et al., EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA, Neurology, 43(4), 1993, pp. 332-332
Risultati: 1-22 |